Drugs@FDA: FDA-Approved Drugs
Abbreviated New Drug Application (ANDA): 203729
Company: AMNEAL PHARMS
Company: AMNEAL PHARMS
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
|---|---|---|---|---|---|---|---|
| QUININE SULFATE | QUININE SULFATE | 324MG | CAPSULE;ORAL | Prescription | AB | No | No |
Original Approvals or Tentative Approvals
| Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
|---|---|---|---|---|---|---|---|
| 07/15/2015 | ORIG-1 | Approval |
Label is not available on this site. |
Supplements
| Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert | Note | Url |
|---|---|---|---|---|---|
| 12/13/2019 | SUPPL-2 | Labeling-Package Insert, Labeling-Medication Guide |
Label is not available on this site. |
QUININE SULFATE
CAPSULE;ORAL; 324MG
TE Code = AB
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | RLD | TE Code | Application No. | Company |
|---|---|---|---|---|---|---|---|---|
| QUININE SULFATE | QUININE SULFATE | 324MG | CAPSULE;ORAL | Prescription | No | AB | 203729 | AMNEAL PHARMS |
| QUININE SULFATE | QUININE SULFATE | 324MG | CAPSULE;ORAL | Prescription | No | AB | 204372 | INGENUS PHARMS LLC |
| QUININE SULFATE | QUININE SULFATE | 324MG | CAPSULE;ORAL | Prescription | No | AB | 203112 | LUPIN |
| QUININE SULFATE | QUININE SULFATE | 324MG | CAPSULE;ORAL | Prescription | No | AB | 091661 | TEVA PHARMS |